96 related articles for article (PubMed ID: 7411766)
1. Leg pain and platelet aggregates in thrombocythemic myeloproliferative disease.
Salem HH; van der Weyden MB; Koutts J; Firkin BG
JAMA; 1980 Sep; 244(10):1122-3. PubMed ID: 7411766
[TBL] [Abstract][Full Text] [Related]
2. Abnormal platelet function in myeloproliferative disorders.
Waddell CC; Brown JA; Repinecz YA
Arch Pathol Lab Med; 1981 Aug; 105(8):432-5. PubMed ID: 6894852
[TBL] [Abstract][Full Text] [Related]
3. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
[TBL] [Abstract][Full Text] [Related]
4. [Platelet function in chronic myeloproliferative syndromes associated with thrombocytosis].
Grebe G; Pereira J; Mezzano D; Legues ME; Aranda E; Lira P
Rev Med Chil; 1985 Jan; 113(1):32-7. PubMed ID: 4081383
[No Abstract] [Full Text] [Related]
5. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.
Ludwig H; Linkesch W; Gisslinger H; Fritz E; Sinzinger H; Radaszkiewicz T; Chott A; Flener R; Micksche M
Cancer Immunol Immunother; 1987; 25(3):266-73. PubMed ID: 3677127
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of the control of antiplatelet therapy through platelet aggregation rate on polycythemia vera associated with thrombocytosis and erythromelalgia].
Kurihara A; Kobayashi I; Tamura K
Rinsho Ketsueki; 1989 Jan; 30(1):99-104. PubMed ID: 2716205
[TBL] [Abstract][Full Text] [Related]
8. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
Hochhaus A; Mindner K; Ostermann G; Höche D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
[TBL] [Abstract][Full Text] [Related]
9. Anagrelide for control of thrombocytosis due to myeloproliferative disorders.
Harrison CN
Future Oncol; 2005 Oct; 1(5):609-18. PubMed ID: 16556037
[TBL] [Abstract][Full Text] [Related]
10. Bleeding and thrombosis in the myeloproliferative disorders.
Schafer AI
Blood; 1984 Jul; 64(1):1-12. PubMed ID: 6375757
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytosis, circulating platelet aggregates, and neurological dysfunction.
Preston FE; Martin JF; Stewart RM; Davies-Jones GA
Br Med J; 1979 Dec; 2(6204):1561-3. PubMed ID: 534868
[TBL] [Abstract][Full Text] [Related]
12. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
[TBL] [Abstract][Full Text] [Related]
13. Which tests are most useful in distinguishing between reactive thrombocytosis and the thrombocytosis of myeloproliferative disease?
Majer RV; Dawe A; Weir P; Jones-Lecointe A; Green PJ
Clin Lab Haematol; 1991; 13(1):9-15. PubMed ID: 2060267
[TBL] [Abstract][Full Text] [Related]
14. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
[No Abstract] [Full Text] [Related]
15. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
[TBL] [Abstract][Full Text] [Related]
16. Gangrene of the toes with palpable peripheral pulses.
Morris-Jones W; Preston FE; Greaney M; Chatterjee DK
Ann Surg; 1981 Apr; 193(4):462-6. PubMed ID: 7212809
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
18. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
19. Platelet number and platelet function: their importance in hemostasis.
Moore A
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):441-2. PubMed ID: 6538504
[No Abstract] [Full Text] [Related]
20. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
